Skip to main content
DNA Labs India

AICDA Gene Immunodeficiency type 2, with hyper-IgM NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

AICDA Gene Immunodeficiency type 2, with hyper-IgM NGS Genetic Test

Short Name: AICDA Gene Immunodeficiency Type 2 NGS Test

Also known as: Hyper-IgM Syndrome Type 2, AICDA Deficiency

AICDA Gene Immunodeficiency type 2, with hyper-IgM NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS), Genetic Sequencing on Blood samples. Results in 3 to 4 Weeks. Free home collection in 300+ cities across India.

NGS Genetic Test🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of the AICDA Gene Immunodeficiency Type 2 NGS Genetic Test is to identify mutations in the AICDA gene responsible for hyper-IgM syndrome. This test aids in confirming diagnosis, assessing disease severity, guiding treatment decisions, and facilitating family planning through genetic counseling.

Test Code
5009
Price
₹20,000
Sample Type
Blood
Result Time
3 to 4 Weeks
Fasting Required
No
Method
Next-Generation Sequencing (NGS), Genetic Sequencing
Step 1

Sample Collection

Clinical history of the patient and a genetic counseling session to draw a pedigree chart of family members affected with AICDA Gene Immunodeficiency Type 2.

Method: Venipuncture

Step 2

Laboratory Analysis

Standard blood collection via venipuncture under aseptic conditions.

Step 3

Report Delivery

Apply pressure to the puncture site to prevent bleeding; monitor for any adverse reactions.

Timeline: 3 to 4 Weeks

Patient Instructions

1
Before the Test:Complete clinical history and genetic counseling are required before sample collection.
2
During the Test:Blood sample is collected and sent for NGS analysis in the laboratory.
3
After the Test:Results are available in 3 to 4 weeks; follow-up with a healthcare professional is recommended.

About This Test

Who Should Get This Test

The purpose of the AICDA Gene Immunodeficiency Type 2 NGS Genetic Test is to identify mutations in the AICDA gene responsible for hyper-IgM syndrome. This test aids in confirming diagnosis, assessing disease severity, guiding treatment decisions, and facilitating family planning through genetic counseling.

How to Prepare

  • Provide detailed clinical history
  • Attend genetic counseling session
  • Ensure proper identification of patient

Doctor's Notes

Reviewed by — MBBS, MD (Pathology) · Reg. No. 21521

"Genetic testing for AICDA mutations is crucial for diagnosing hyper-IgM syndrome and guiding personalized treatment plans."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood
Sample Volume5 mL
ContainerEDTA tube
Collection MethodVenipuncture

Sample Stability

Blood sample stable for 48 hours at 2-8°C
Sample Rejection Criteria:
  • Hemolyzed sample
  • Insufficient sample volume
  • Incorrect labeling

Understanding Your Results

Results indicate the presence or absence of pathogenic mutations in the AICDA gene. Positive results confirm AICDA Gene Immunodeficiency Type 2, while negative results may require further clinical evaluation.
📊

Positive for pathogenic variant

Confirms diagnosis of AICDA Gene Immunodeficiency Type 2; recommend specialist consultation and management.

📊

Negative for pathogenic variant

No mutations detected; consider other genetic or immunological tests if symptoms persist.

⚠️ When to Consult a Doctor:

Consult a doctor if symptoms such as frequent infections, chronic diarrhea, or growth failure persist, or if there is a family history of immunodeficiency disorders.

Limitations

  • May not detect all genetic variants
  • Results require clinical correlation

Risks & Considerations

  • Minor bruising at puncture site
  • Rare risk of infection

Interfering Factors

  • Sample contamination
  • Improper sample storage

Frequently Asked Questions

What is AICDA Gene Immunodeficiency Type 2?
It is a rare genetic disorder caused by mutations in the AICDA gene, leading to impaired antibody production and hyper-IgM syndrome.
What are the common symptoms?
Symptoms include frequent infections, chronic diarrhea, recurrent respiratory tract infections, enlarged lymph nodes, growth failure, and autoimmune disorders.
How is the test performed?
The test uses Next-Generation Sequencing (NGS) to analyze the AICDA gene from a blood sample.
What is the cost of the test in India?
The cost is INR 20,000 at DNA Labs India, with free home sample collection available.
Is home sample collection available?
Yes, DNA Labs India offers free home sample collection across many cities in India.
How long does it take to get results?
Results are typically available within 3 to 4 weeks after sample collection.
Is genetic counseling required before testing?
Yes, a genetic counseling session is recommended to understand the test implications and draw a family pedigree chart.
Can the test detect all mutations?
The NGS test is comprehensive but may not detect all possible genetic variants; clinical correlation is advised.
What if the test result is positive?
A positive result confirms the diagnosis; consult a healthcare professional for management and treatment options.
Is the test covered by insurance?
Coverage depends on the insurance provider; check with your insurer for details.
How accurate is the NGS genetic test?
NGS is highly accurate for detecting pathogenic mutations, but results should be interpreted by a qualified professional.
Who should consider getting tested?
Individuals with symptoms of immunodeficiency, a family history of hyper-IgM syndrome, or those recommended by a healthcare provider.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.